Literature DB >> 15452225

Identification of differentially expressed genes in scrapie-infected mouse brains by using global gene expression technology.

Wei Xiang1, Otto Windl, Gerda Wünsch, Martin Dugas, Alexander Kohlmann, Nicola Dierkes, Ingo M Westner, Hans A Kretzschmar.   

Abstract

The pathogenesis of prion diseases, a class of transmissible fatal neurodegenerative diseases in humans and animals, is still unclear. The aim of this study was to identify the differentially regulated genes that correlate with the development of prion diseases for a better understanding of their pathological mechanisms. We employed Affymetrix Mouse Expression Arrays 430A containing >22,000 transcripts and compared the global gene expression profiles from brains of mice who were intracerebrally inoculated with scrapie strains ME7 and RML with those from brains of uninfected and mock-infected mice. The microarray data were analyzed by Significance Analysis of Microarrays, revealing 121 genes whose expression increased at least twofold in both ME7- and RML-infected mouse brains, with an estimated false discovery rate of < or =5%. These genes encode proteins involved in proteolysis, protease inhibition, cell growth and maintenance, the immune response, signal transduction, cell adhesion, and molecular metabolism. The time course of expression generally showed up-regulation of these genes from 120 days postinoculation (dpi) for ME7-inoculated mouse brains and from 90 dpi for RML-inoculated mouse brains. The onset of elevated expression correlated temporally with the onset of PrP(Sc) accumulation and the activation of glia, which may have contributed to neuronal cell death. Among the differentially regulated genes reported in the present study, the emergence of genes for several cathepsins and S100 calcium binding proteins was conspicuous. These and other genes reported here may represent novel potential diagnostic and therapeutic targets for prion disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15452225      PMCID: PMC521804          DOI: 10.1128/JVI.78.20.11051-11060.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Acidic calponin immunoreactivity in postnatal rat brain and cultures: subcellular localization in growth cones, under the plasma membrane and along actin and glial filaments.

Authors:  M Plantier; A Fattoum; B Menn; Y Ben-Ari; E Der Terrossian; A Represa
Journal:  Eur J Neurosci       Date:  1999-08       Impact factor: 3.386

2.  Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.

Authors:  M Ashburner; C A Ball; J A Blake; D Botstein; H Butler; J M Cherry; A P Davis; K Dolinski; S S Dwight; J T Eppig; M A Harris; D P Hill; L Issel-Tarver; A Kasarskis; S Lewis; J C Matese; J E Richardson; M Ringwald; G M Rubin; G Sherlock
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

3.  Identification of upregulated genes in scrapie-infected brain tissue.

Authors:  C Riemer; I Queck; D Simon; R Kurth; M Baier
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  Encephalopathy in mice produced by inoculation with scrapie brain material.

Authors:  R L CHANDLER
Journal:  Lancet       Date:  1961-06-24       Impact factor: 79.321

5.  Late increase of serum S100 beta protein levels in hamsters after oral or intraperitoneal infection with scrapie.

Authors:  M Beekes; M Otto; J Wiltfang; E Bahn; S Poser; M Baier
Journal:  J Infect Dis       Date:  1999-08       Impact factor: 5.226

6.  Expression of cytokine genes and increased nuclear factor-kappa B activity in the brains of scrapie-infected mice.

Authors:  J I Kim; W K Ju; J H Choi; E Choi; R I Carp; H M Wisniewski; Y S Kim
Journal:  Brain Res Mol Brain Res       Date:  1999-11-10

Review 7.  New perspectives on S100 proteins: a multi-functional Ca(2+)-, Zn(2+)- and Cu(2+)-binding protein family.

Authors:  C W Heizmann; J A Cox
Journal:  Biometals       Date:  1998-12       Impact factor: 2.949

8.  Cystatin F is a glycosylated human low molecular weight cysteine proteinase inhibitor.

Authors:  J Ni; M A Fernandez; L Danielsson; R A Chillakuru; J Zhang; A Grubb; J Su; R Gentz; M Abrahamson
Journal:  J Biol Chem       Date:  1998-09-18       Impact factor: 5.157

9.  Differential expression of S100B and S100A6(1) in the human fetal and aged cerebral cortex.

Authors:  S C Tiu; W Y Chan; C W Heizmann; B W Schäfer; S Y Shu; D T Yew
Journal:  Brain Res Dev Brain Res       Date:  2000-02-07

10.  Participation of a cathepsin L-type protease in the activation of caspase-3.

Authors:  R Ishisaka; T Utsumi; T Kanno; K Arita; N Katunuma; J Akiyama; K Utsumi
Journal:  Cell Struct Funct       Date:  1999-12       Impact factor: 2.212

View more
  72 in total

1.  IL-1 family members as candidate genes modulating scrapie susceptibility in sheep: localization, partial characterization, and expression.

Authors:  Ane Marcos-Carcavilla; Jorge H Calvo; Carmen González; Katayoun Moazami-Goudarzi; Pascal Laurent; Maud Bertaud; Hélène Hayes; Anne E Beattie; Carmen Serrano; Jaber Lyahyai; Inmaculada Martín-Burriel; Estefânia Alves; Pilar Zaragoza; Juan J Badiola; Magdalena Serrano
Journal:  Mamm Genome       Date:  2007-01-22       Impact factor: 2.957

Review 2.  Finding diamonds in the rubble.

Authors:  Jang-Ho J Cha
Journal:  Exp Neurol       Date:  2007-02-20       Impact factor: 5.330

3.  Transcriptome signature of virulent and attenuated pseudorabies virus-infected rodent brain.

Authors:  Christina Paulus; Patricia J Sollars; Gary E Pickard; Lynn W Enquist
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

4.  Proteolysis of prion protein by cathepsin S generates a soluble beta-structured intermediate oligomeric form, with potential implications for neurotoxic mechanisms.

Authors:  Oxana Polyakova; Denise Dear; Igor Stern; Stephen Martin; Elizabeth Hirst; Suleman Bawumia; Angus Nash; Guy Dodson; Igor Bronstein; Peter M Bayley
Journal:  Eur Biophys J       Date:  2008-09-24       Impact factor: 1.733

5.  Microdissection and transcriptional profiling: a window into the pathobiology of preclinical prion disease.

Authors:  Anna Majer; Stephanie A Booth
Journal:  Prion       Date:  2014 Jan-Feb       Impact factor: 3.931

6.  Identification of chemoattractive factors involved in the migration of bone marrow-derived mesenchymal stem cells to brain lesions caused by prions.

Authors:  Chang-Hyun Song; Osamu Honmou; Hidefumi Furuoka; Motohiro Horiuchi
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

7.  Region-specific glial homeostatic signature in prion diseases is replaced by a uniform neuroinflammation signature, common for brain regions and prion strains with different cell tropism.

Authors:  Natallia Makarava; Jennifer Chen-Yu Chang; Kara Molesworth; Ilia V Baskakov
Journal:  Neurobiol Dis       Date:  2020-01-27       Impact factor: 5.996

Review 8.  Application of "omics" to prion biomarker discovery.

Authors:  Rhiannon L C H Huzarewich; Christine G Siemens; Stephanie A Booth
Journal:  J Biomed Biotechnol       Date:  2010-03-04

9.  Analysis of protein levels of 24 cytokines in scrapie agent-infected brain and glial cell cultures from mice differing in prion protein expression levels.

Authors:  Déborah Tribouillard-Tanvier; James F Striebel; Karin E Peterson; Bruce Chesebro
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

10.  Comparative prion disease gene expression profiling using the prion disease mimetic, cuprizone.

Authors:  Laura R Moody; Allen J Herbst; Han Sang Yoo; Joshua P Vanderloo; Judd M Aiken
Journal:  Prion       Date:  2009-04-19       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.